What is the Difference between CA4P and Other Anti-Angiogenesis Agents?

Krishnansu S. Tewari, MD of University of California, Irvine explains the different between the new drug CA4p and other anti-angiogenesis agents in ovarian cancer. This was recorded at the 2017 ASCO A... Author: ASCO2017 Added: 06/02/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts